Condition
Macular Diseases
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting1
Completed1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06893965Not ApplicableRecruitingPrimary
Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
NCT07165626Not ApplicableEnrolling By Invitation
Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy
NCT02683694Not ApplicableCompletedPrimary
Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases
Showing all 3 trials